Clinical trials: Neural Response in Caudate
Neural Response in Caudate, Weight Loss Trial
The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity
The aims of this project are to determine if dietary supplementation with NOPE-EGCG (PhosphoLeantm, 30mg NOPE+20mg EGCG per capsule) can: rescue striatal function, increase adherence to a diet, reduce weight-gain after a diet…
- Conditions
- Neural Response in Caudate, Weight Loss Trial, Impulsivity
- Trial name
- CIDO OEA (NCT01976156)
- Testing
- PhosphoLean
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Yale University